LAVAL, Quebec, May 27, 2021 /CNW/ -- Bausch Health Companies
Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today
announced it will reduce debt by $100
million through the redemption of outstanding senior notes,
using cash generated from operations.
Bausch Health will redeem $100
million aggregate principal amount of its outstanding 6.125%
Senior Notes due 2025, CUSIP Nos. 91831A AC5, C96729 AC9 (the
"Notes") on June 30, 2021. With the
redemption announced today, the Company will have redeemed a total
of $500 million aggregate principal
amount of debt in 2021 using cash generated from operations.
The Company will issue today an irrevocable notice of redemption
for the Notes, and a copy will be issued to the record holders of
such Notes. Nothing contained herein shall constitute a notice of
redemption of the Notes. Payment of the redemption price and
surrender of the Notes for redemption will be made through the
facilities of the Depository Trust Company in accordance with the
applicable procedures of the Depository Trust Company. The name and
address of the paying agent are as follows: The Bank of New York
Mellon; 111 Sanders Creek Parkway, East
Syracuse, N.Y. 13057; Attn: Redemption Unit; Tel:
800-254-2826.
About Bausch Health
Bausch Health Companies
Inc. (NYSE/TSX: BHC) is a global company whose mission is to
improve people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. For more information, visit
www.bauschhealth.com and connect with us on Twitter and
LinkedIn.
Caution Regarding Forward-Looking Information and "Safe
Harbor" Statement
This news release may contain
forward-looking statements, including, but not limited to, the
redemption of the Notes. Forward-looking statements may generally
be identified by the use of the words "anticipates," "expects,"
"intends," "plans," "should," "could," "would," "may," "will,"
"believes," "estimates," "potential," "target," or "continue" and
variations or similar expressions. These statements are based upon
the current expectations and beliefs of management and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to, risks and uncertainties discussed in the Company's most
recent annual and quarterly reports and detailed from time to time
in the Company's other filings with the Securities and Exchange
Commission and the Canadian Securities Administrators, which
factors are incorporated herein by reference. They also include,
but are not limited to, risks and uncertainties caused by or
relating to the evolving COVID-19 pandemic, and the fear of that
pandemic and its potential effects, the severity, duration and
future impact of which are highly uncertain and cannot be
predicted, and which may have a material adverse impact on the
Company, including but not limited to its supply chain, third-party
suppliers, project development timelines, employee base, liquidity,
stock price, financial condition and costs (which may increase) and
revenue and margins (both of which may decrease). Readers are
cautioned not to place undue reliance on any of these
forward-looking statements. These forward-looking statements speak
only as of the date hereof. Bausch Health undertakes no obligation
to update any of these forward-looking statements to reflect events
or circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-1198
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-health-to-reduce-debt-by-100-million-using-cash-generated-from-operations-301300215.html
SOURCE Bausch Health Companies Inc.